表紙
市場調查報告書

全球電泳試劑市場:各產品(凝膠、染料、緩衝液)、技術、終端用戶、地區(2018年∼2023年)

Electrophoresis Reagents Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 707230
出版日期 內容資訊 英文 116 Pages
商品交期: 2-3個工作天內
價格
全球電泳試劑市場:各產品(凝膠、染料、緩衝液)、技術、終端用戶、地區(2018年∼2023年) Electrophoresis Reagents Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 116 Pages
簡介

全球電泳試劑市場,預計從預測期間的2018年到2023年以約5.2%的年複合成長率發展。

本報告提供全球電泳試劑市場調查,市場概要,各產品、技術、終端用戶、地區的市場規模的變化與預測,市場趨勢,市場成長要素及阻礙因素分析,波特的五力分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 電泳試劑市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 市場動態

  • 成長要素
    • 基因及蛋白質組研究的資金籌措的增加
    • 慢性疾病的盛行率上升
    • 產學聯合的擴大
    • 技術開發
  • 阻礙因素
    • 花費時間的操作
    • 替代技術的存在
  • 市場機會
  • 課題

第7章 市場分析:各市場區隔

  • 各產品
    • 凝膠
    • 染料
    • 緩衝液
    • 其他試劑
  • 各技術
    • 凝膠電泳
    • 毛細管電泳法
  • 各終端用戶
    • 學術、研究機關
    • 製藥、生物科技企業
    • 研究所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 企業簡介和競爭情形

  • Agilent Technologies, Inc.
  • BioAtlas
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Lonza Group, AG
  • Merck KGaA
  • Qiagen NV
  • Sigma-Aldrich Corporation
  • TaKaRa BIO
  • Thermo Fisher Scientific

第9章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 62785

Market Overview

The propelling factors for the growth of the electrophoresis reagents market include the increased funding for genomic and proteomic research, the rising prevalence of chronic diseases, increasing collaborations between industry and academics, and the technological developments.

The prevalence of chronic diseases is expected to increase by 57% by 2020. Additionally, as per WHO, China and India now have the world's highest number of diabetes sufferers at more than 98 million and 65 million individuals. With the increasing prevalence of chronic diseases, prompt diagnosis and treatment are in need. Therefore, this has given rise to the electrophoresis that is used in the clinical laboratories to quantify the lipoproteins using enzymatic staining of cholesterol and triglycerides for the diagnosis of CVD and other chronic diseases, like diabetes. The electrophoresis is used in the analysis of the lipoproteins and apolipoproteins that are essential for the valuation of the CVD and monitoring of individuals on treatment.

Furthermore, the development of this market is also significantly determined by the expanding research exercises in the fields of proteomics and genomics, changing administrative necessities in the pharmaceutical part, and the developing need to reduce the healthcare expenses.

Moreover, factors like rising per capita income and increasing public healthcare expenditure are also expected to promote the growth of electrophoresis reagents market over the forecast period.

Scope of the Report

As per the scope of the report, electrophoresis is a technique used to separate DNA, RNA, and proteins using an electrical current based on the molecular weight or fragment size. The electrophoresis reagents being used in the electrophoresis technique are known as electrophoresis reagents. This technology is widely used in the fields of medical diagnostics and life sciences and clinical research. The electrophoresis technique uses different reagents, such as dyes, gels, and buffers for the separation of different molecules. Although this technique has been in use for a long time and is considered outdated, with the addition of latest technologies, the market is growing at a steady rate.

Key Market Trends

Gel Electrophoresis is the Largest Segment Under Technique That is Also Expected to Continue During the Forecast Period

Gel electrophoresis segment accounted for the largest market share of electrophoresis reagents market, mainly due to the low operating and instrument cost. It is, thus, being followed by capillary electrophoresis, because of rising applications in the pharmaceutical and biotechnology industries.

Asia-Pacific Region is the Fastest Growing Market and is Expected to Follow the Same Trend Over the Forecast Period

The Asia-Pacific region is expected to dominate the electrophoresis reagents market. In the emerging economies of China, Japan, and India, there has been an increasing number of academic and research institutions, technological advancements, pharmaceutical, and biotechnology companies, and health awareness. The high growth is also majorly attributed to the rapidly improving healthcare infrastructure and low labor costs in emerging countries.

Competitive Landscape

The major players are found adopting various strategies, such as agreements, expansion, contracts, partnerships, new reagent development, joint ventures, and mergers and acquisitions in order to strengthen their position in the electrophoresis reagents market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Funding for Genomic and Proteomic Research
    • 4.2.2 Rising Prevalence of Chronic Diseases
    • 4.2.3 Increasing Collaborations between Industry and Academics
    • 4.2.4 Technological Developments
  • 4.3 Market Restraints
    • 4.3.1 Time-consuming Operations
    • 4.3.2 Presence of Alternative Technologies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Gels
      • 5.1.1.1 Agarose Gels
      • 5.1.1.2 Polyacrylamide Gels
      • 5.1.1.3 Starch Gels
    • 5.1.2 Dyes
      • 5.1.2.1 Ethidium Bromide (ETBR) Dyes
      • 5.1.2.2 Bromophenol Blue
      • 5.1.2.3 Sybr Dyes
      • 5.1.2.4 Other Dyes
    • 5.1.3 Buffers
      • 5.1.3.1 Tris/Acetate/EDTA
      • 5.1.3.2 Tris/Borate/EDTA
      • 5.1.3.3 Other Buffers
    • 5.1.4 Other Products
  • 5.2 By Technique
    • 5.2.1 Gel Electrophoresis
    • 5.2.2 Capillary Electrophoresis
  • 5.3 By End User
    • 5.3.1 Academic and Research Institutions
    • 5.3.2 Pharmaceutical and Biotechnology Companies
    • 5.3.3 Laboratories
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 BioAtlas
    • 6.1.3 Bio-Rad Laboratories Inc.
    • 6.1.4 GE Healthcare
    • 6.1.5 Lonza Group AG
    • 6.1.6 Merck KGaA
    • 6.1.7 Qiagen NV
    • 6.1.8 Sigma-Aldrich Corporation
    • 6.1.9 Takara Bio Inc.
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS